BG

Bellevue Group Portfolio holdings

AUM $4.54B
This Quarter Return
+4.25%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
AUM
$1.01B
AUM Growth
+$1.01B
Cap. Flow
+$23.9M
Cap. Flow %
2.37%
Top 10 Hldgs %
32.72%
Holding
140
New
6
Increased
28
Reduced
48
Closed
16
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IRTC icon
76
iRhythm Technologies
IRTC
$5.46B
$2.1M 0.21% 33,400
HCA icon
77
HCA Healthcare
HCA
$94.5B
$2.07M 0.2% 21,300
RARE icon
78
Ultragenyx Pharmaceutical
RARE
$2.89B
$2.06M 0.2% 40,300 -600 -1% -$30.6K
SAGE
79
DELISTED
Sage Therapeutics
SAGE
$2.01M 0.2% 12,450 -200 -2% -$32.2K
ICPT
80
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.96M 0.19% 31,900 +12,500 +64% +$769K
MCK icon
81
McKesson
MCK
$85.4B
$1.94M 0.19% 13,800
PEN icon
82
Penumbra
PEN
$10.6B
$1.94M 0.19% 16,800
ITCI
83
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.92M 0.19% 91,000 -1,500 -2% -$31.6K
DVAX icon
84
Dynavax Technologies
DVAX
$1.19B
$1.88M 0.19% 94,500 +39,500 +72% +$784K
ANGO icon
85
AngioDynamics
ANGO
$417M
$1.75M 0.17% 101,700
EGRX
86
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.74M 0.17% 33,000
NUVA
87
DELISTED
NuVasive, Inc.
NUVA
$1.69M 0.17% 32,312
CHRS icon
88
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$1.66M 0.16% 150,000
HCSG icon
89
Healthcare Services Group
HCSG
$1.13B
$1.65M 0.16% 38,000
CLLS
90
Cellectis
CLLS
$258M
$1.64M 0.16% 52,100 +27,750 +114% +$875K
BHC icon
91
Bausch Health
BHC
$2.74B
$1.59M 0.16% +100,000 New +$1.59M
PODD icon
92
Insulet
PODD
$23.9B
$1.56M 0.15% 18,000
TEVA icon
93
Teva Pharmaceuticals
TEVA
$21.1B
$1.54M 0.15% 90,000 -581,940 -87% -$9.94M
AET
94
DELISTED
Aetna Inc
AET
$1.52M 0.15% 9,000 -13,000 -59% -$2.2M
XENT
95
DELISTED
Intersect ENT, Inc
XENT
$1.51M 0.15% 38,430
MASI icon
96
Masimo
MASI
$7.59B
$1.5M 0.15% 17,000
HALO icon
97
Halozyme
HALO
$8.56B
$1.49M 0.15% 75,800 -1,200 -2% -$23.5K
IPXL
98
DELISTED
Impax Laboratories, Inc.
IPXL
$1.46M 0.14% 75,000
QTRX icon
99
Quanterix
QTRX
$211M
$1.43M 0.14% 83,800
PTLA
100
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.4M 0.14% 42,700 -650 -1% -$21.2K